We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Digital 3D model of a protein structure representing data-driven proteomics research.
Industry Insight

Beyond Mutations: Inside Immuto’s Quest To Decode Disease Structure

Immuto Scientific’s structural surfaceomics platform reveals how wild-type proteins adopt disease-specific shapes that drive pathology. Immuto identifies previously invisible drug targets and designs conformation-selective therapies.
Blue drug capsule with lower half made from computer network and the upper half containing small human brains.
Industry Insight

AI-Powered Platforms Are Making Complex Data Usable for Drug Discovery

In this interview, we explore how Sonrai is advancing reproducible science, enabling cross-disciplinary collaboration and shaping the future of AI-powered drug discovery.
Microscopic view of kidney tissue stained pink and green.
Industry Insight

How AI Is Accelerating the Digital Transformation of Pathology

Technology Networks spoke with Dr. Olga Colgan and Dr. Joseph Chiweshe to learn how AI-driven digital pathology is reshaping diagnostic workflows.
A researcher holding up a drug vial to the camera. A image of a DNA double helix is digitally-superimposed onto the blue liquid in the vial.
Industry Insight

Circular RNA: The Next Frontier for RNA Therapeutics?

Discover how circular RNA and targeted delivery technologies are advancing RNA therapeutics for chronic diseases and vaccines.
A doctor in a white coat with an outstretched hand. In the hand is a digitally-imposed red and white drug pill, shimmering with data-like light points surrounding it.
Industry Insight

Can Patients Trust a Drug Designed By AI?

Patient trust is vital as AI transforms pharma and drug discovery. Discover how transparency and regulation are making innovation safer.
A digital illustration showing a double helix DNA strand in vivid blue, superimposed over a wireframe model of a human head and a blurred full-body figure in the background.
Industry Insight

Genomics Testing Needs Structured Data To Succeed

Dr. Heidi Rehm shares insights on how genomics is evolving at the intersection of research and clinical practice. In this Q&A, she highlights the role of AI, global data standards and collaboration in shaping future patient care.
DNA helix shape made from lots of individuals.
Industry Insight

Building Infinity™: How GeneDx Is Transforming Rare Disease Diagnosis

Families with rare diseases often wait years for answers. GeneDx’s AI-driven dataset, Infinity™, is changing that. In this interview, Dr. Bryan Dechario explains how decades of data are reshaping the future of genomic medicine.
3D visualization of protein structures and spatial data used in deep visual proteomics analysis.
Industry Insight

Advances in Deep Visual Proteomics With Dr. Andreas Mund

Deep Visual Proteomics integrates high-resolution imaging, AI and ultra-sensitive mass spectrometry to map proteins at single-cell resolution while preserving spatial context.
A speaker presenting at the Lab of the Future Europe Congress, with a packed room of audience members. Focal point is the presentation deck with a darkened room of audience heads.
Industry Insight

Tomorrow, Today: Experts Discuss the Lab of the Future

In this article, we explore how AI, robotics and advanced software are transforming biopharma labs, the challenges of adopting these technologies and the vision for the “Lab of the Future.”
3D rendering of transparent human body highlighting internal organs for targeted drug delivery research.
Industry Insight

How Nanoparticles Are Revolutionizing Drug Delivery

In this interview, Dr. Freya Leech, a researcher at NanoFCM, discusses the current challenges and future prospects in nanoparticle drug delivery.
Advertisement